Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Blinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia.
This report elaborates on the current development of the Blinatumomab industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Amgen
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Prefilled
Non-prefilled
Application:
Hospital
Pharmacy
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Blinatumomab Industry Overview
-
1.1.1 Blinatumomab Market Scope and Market Segments
-
1.1.2 Blinatumomab Industry Characteristics
-
1.1.3 Global and China Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Blinatumomab Production Value and Growth Rate (2017-2028)
-
1.2 Global Blinatumomab Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Prefilled
-
1.2.2 Non-prefilled
-
1.3 Global Blinatumomab Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Pharmacy
-
1.4 Market Analysis by Region
-
1.4.1 North America Blinatumomab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Blinatumomab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Blinatumomab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Blinatumomab Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Blinatumomab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Blinatumomab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Blinatumomab Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Blinatumomab Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Blinatumomab Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Blinatumomab Industry Porter's Five Forces Model Analysis
-
2.2.3 Blinatumomab Industry PEST Analysis
-
2.3 Blinatumomab Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Blinatumomab Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Blinatumomab Industry
Chapter 3 Global and China Blinatumomab Market, by Manufacturer
-
3.1 Global and China Blinatumomab Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Blinatumomab Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Blinatumomab Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Blinatumomab Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Blinatumomab Market Top 3 Players
Chapter 4 Global and China Blinatumomab Market, by Type (2017-2028)
-
4.1 Blinatumomab Market Trend, by Type
-
4.2 Global Blinatumomab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Blinatumomab Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Blinatumomab Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Blinatumomab Price Trend, by Type (2017-2028)
-
4.3 China Blinatumomab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Blinatumomab Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Blinatumomab Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Blinatumomab Price Trend, by Type (2017-2028)
Chapter 5 Global and China Blinatumomab Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Blinatumomab Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Blinatumomab Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Blinatumomab Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Blinatumomab Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Blinatumomab Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Blinatumomab Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Blinatumomab Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Blinatumomab Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Blinatumomab Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Blinatumomab Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Blinatumomab Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Blinatumomab Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Blinatumomab Market Analysis
-
7.1 North America Blinatumomab Market, by Type
-
7.2 North America Blinatumomab Market, by Application
-
7.3 North America Blinatumomab Market Analysis and Forecast, by Country
-
7.3.1 United States Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Blinatumomab Market Analysis
-
8.1 Europe Blinatumomab Market, by Type
-
8.2 Europe Blinatumomab Market, by Application
-
8.3 Europe Blinatumomab Market Analysis and Forecast, by Country
-
8.3.1 Germany Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Blinatumomab Market Analysis
-
9.1 APAC Blinatumomab Market, by Type
-
9.2 APAC Blinatumomab Market, by Application
-
9.3 APAC Blinatumomab Market Analysis and Forecast, by Country
-
9.3.1 China Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Blinatumomab Market Analysis
-
10.1 Latin America, Middle East and Africa Blinatumomab Market, by Type
-
10.2 Latin America, Middle East and Africa Blinatumomab Market, by Application
-
10.3 Latin America, Middle East and Africa Blinatumomab Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Blinatumomab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Blinatumomab Company Profiles
-
11.1 Amgen
-
11.1.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Amgen Blinatumomab Product Profiles, Application and Specification
-
11.1.3 Amgen Blinatumomab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Blinatumomab Industry Investment Prospect and Risk Assessment
-
12.1 Blinatumomab Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Blinatumomab Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure China Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Global Blinatumomab Production Value and Growth Rate (2017-2028)
-
Figure China Blinatumomab Production Value and Growth Rate (2017-2028)
-
Figure Global Blinatumomab Market Size and Growth Rate of Prefilled (2017-2028)
-
Figure Global Blinatumomab Market Size and Growth Rate of Non-prefilled (2017-2028)
-
Figure Global Blinatumomab Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Blinatumomab Market Size and Growth Rate of Pharmacy (2017-2028)
-
Figure North America Blinatumomab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Blinatumomab Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Blinatumomab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Blinatumomab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Blinatumomab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Blinatumomab Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Blinatumomab Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Blinatumomab Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Blinatumomab Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Blinatumomab Market Share, by Manufacturer in 2021
-
Figure Global and China Blinatumomab Market Share, by Manufacturer in 2022
-
Table Global Blinatumomab Sales Volume, by Type (2017-2028)
-
Table Global Blinatumomab Sales Volume Share, by Type (2017-2028)
-
Figure Global Blinatumomab Sales Volume Share, by Type (2017-2028)
-
Table Global Blinatumomab Sales Value, by Type (2017-2028)
-
Table Global Blinatumomab Sales Value Share, by Type (2017-2028)
-
Figure Global Blinatumomab Price Trend, by Type (2017-2028)
-
Table China Blinatumomab Sales Volume, by Type (2017-2028)
-
Table China Blinatumomab Sales Volume Share, by Type (2017-2028)
-
Figure China Blinatumomab Sales Volume Share, by Type (2017-2028)
-
Table China Blinatumomab Sales Value, by Type (2017-2028)
-
Table China Blinatumomab Sales Value Share, by Type (2017-2028)
-
Figure China Blinatumomab Price Trend, by Type (2017-2028)
-
Table Global Blinatumomab Sales Volume, by Application (2017-2028)
-
Table Global Blinatumomab Sales Volume Share, by Application (2017-2028)
-
Figure Global Blinatumomab Sales Volume Share, by Application (2017-2028)
-
Table Global Blinatumomab Sales Value, by Application (2017-2028)
-
Table Global Blinatumomab Sales Value Share, by Application (2017-2028)
-
Figure Global Blinatumomab Sales Value Share, by Application (2017-2028)
-
Table China Blinatumomab Sales Volume, by Application (2017-2028)
-
Table China Blinatumomab Sales Volume Share, by Application (2017-2028)
-
Figure China Blinatumomab Sales Volume Share, by Application (2017-2028)
-
Table China Blinatumomab Sales Value, by Application (2017-2028)
-
Table China Blinatumomab Sales Value Share, by Application (2017-2028)
-
Figure China Blinatumomab Sales Value Share, by Application (2017-2028)
-
Figure China Blinatumomab Production, Import, Consumption and Export (2017-2022)
-
Figure North America Blinatumomab Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Blinatumomab Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Blinatumomab Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Blinatumomab Production, Import, Consumption and Export (2017-2022)
-
Table North America Blinatumomab Sales Volume, by Type (2017-2028)
-
Table North America Blinatumomab Sales Volume Share, by Type (2017-2028)
-
Figure North America Blinatumomab Sales Volume Share, by Type (2017-2028)
-
Table North America Blinatumomab Sales Volume, by Application (2017-2028)
-
Table North America Blinatumomab Sales Volume Share, by Application (2017-2028)
-
Figure North America Blinatumomab Sales Volume Share, by Application (2017-2028)
-
Figure United States Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure United States Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Canada Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Table Europe Blinatumomab Sales Volume, by Type (2017-2028)
-
Table Europe Blinatumomab Sales Volume Share, by Type (2017-2028)
-
Figure Europe Blinatumomab Sales Volume Share, by Type (2017-2028)
-
Table Europe Blinatumomab Sales Volume, by Application (2017-2028)
-
Table Europe Blinatumomab Sales Volume Share, by Application (2017-2028)
-
Figure Europe Blinatumomab Sales Volume Share, by Application (2017-2028)
-
Figure Germany Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure UK Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure UK Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure France Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure France Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Italy Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Spain Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Poland Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Russia Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Table APAC Blinatumomab Sales Volume, by Type (2017-2028)
-
Table APAC Blinatumomab Sales Volume Share, by Type (2017-2028)
-
Figure APAC Blinatumomab Sales Volume Share, by Type (2017-2028)
-
Table APAC Blinatumomab Sales Volume, by Application (2017-2028)
-
Table APAC Blinatumomab Sales Volume Share, by Application (2017-2028)
-
Figure APAC Blinatumomab Sales Volume Share, by Application (2017-2028)
-
Figure China Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure China Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Japan Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure India Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure India Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Blinatumomab Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Blinatumomab Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Blinatumomab Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Blinatumomab Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Blinatumomab Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Blinatumomab Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Blinatumomab Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Blinatumomab Sales Value and Growth Rate (2017-2028)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Blinatumomab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
